Verition Fund Management’s Twist Bioscience TWST Stock Holding History

Verition Fund Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.84M	Buy	37,369 +16,699	+81%	+$1.09M	0.02%	781
2026 Q1	$982K	Buy	+20,670	New	+$927K	0.01%	1310
2025 Q4	–	Sell	-12,908	Closed	-$363K	–	3961
2025 Q3	$363K	Buy	+12,908	New	+$391K	﹤0.01%	3206
2025 Q1	–	Sell	-4,570	Closed	-$212K	–	3726
2024 Q4	$212K	Sell	4,570 -20,523	-82%	-$927K	﹤0.01%	2952
2024 Q3	$1.13M	Buy	25,093 +19,054	+316%	+$907K	0.01%	1798
2024 Q2	$298K	Buy	+6,039	New	+$246K	﹤0.01%	2349
2023 Q2	–	Sell	-22,574	Closed	-$340K	–	2560
2023 Q1	$340K	Buy	+22,574	New	+$499K	﹤0.01%	1447

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Verition Fund Management's TWST Position: Q2 2026 in Review

Verition Fund Management increased its Twist Bioscience (TWST) stake by 81% in Q2 2026, buying an estimated $1.09M and bringing the position to 37,369 shares worth $3.84M. The position accounts for 0.02% of the portfolio, ranked #781.

Verition Fund Management first reported a position in TWST in Q1 2023 and has held it in 7 quarters since. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Verition Fund Management held 37,369 shares of Twist Bioscience worth $3.84M as of Q2 2026.
Verition Fund Management bought 16,699 Twist Bioscience shares in Q2 2026, an estimated $1.09M.
Twist Bioscience made up 0.02% of Verition Fund Management's portfolio in Q2 2026, its #781 holding.
Verition Fund Management first reported a position in Twist Bioscience in Q1 2023 and has held it in 7 quarters since.
337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.